109 filings
8-K
Arcturus Therapeutics Holdings, Inc.
1 Aug 19
Entry into a Material Definitive Agreement
12:08pm
8-K
ARCT
Arcturus Therapeutics Holdings Inc
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
8-K
Arcturus Therapeutics Holdings, Inc.
20 May 19
Submission of Matters to a Vote of Security Holders
5:13pm
8-K
Arcturus Therapeutics Holdings, Inc.
13 May 19
Arcturus Therapeutics Announces First Quarter Financial Results and Provides a Corporate Update
5:13pm
8-K
Arcturus Therapeutics Holdings, Inc.
19 Mar 19
Arcturus Therapeutics Provides Corporate Update and Reports Fourth Quarter and Year End 2018 Financial Results
12:00am
8-K
ku02crhyz746sqr sxjl
27 Feb 19
Regulation FD Disclosure
8:00am
8-K
co74j hch
11 Feb 19
Regulation FD Disclosure
12:00am
6-K
ua0vdg06a5ttyaj qs9
6 Nov 18
Current report (foreign)
8:20pm
6-K
zles2nd9rwcx2z3v06zk
15 Oct 18
Arct 6-K 2018-10-15
4:36pm
6-K
fiydm6gl
1 Oct 18
Arcturus Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
12:00am
6-K
avhusv 0wuqp
28 Sep 18
Current report (foreign)
4:07pm
6-K
7cg81fbso ezi
29 Aug 18
Current report (foreign)
12:00am
6-K
q9200okz
27 Jul 18
Notice of Annual and Extraordinary General Meeting of Shareholders
4:15pm
6-K
kywqc 5k0
20 Jul 18
Current report (foreign)
5:26pm
6-K
y4n 4nhqjpts5dno
10 Jul 18
Arcturus Therapeutics Announces Results of Extraordinary General Meeting of Shareholders
4:42pm
6-K
wda4hayuc
15 Jun 18
Extraordinary General Meeting of Shareholders
5:29pm
6-K
865trn
1 Jun 18
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders
12:00am
6-K
6syb63gz5 n0
29 May 18
Current report (foreign)
5:16pm
6-K
5sh3i8g
24 May 18
Current report (foreign)
4:30pm
6-K
gf7u91z3i
21 May 18
ARCTURUS THERAPEUTICS Announces EXTRAORDINARY General Meeting of Shareholders
4:59pm